Establishment Labs Holdings Inc.
A maker of breast implants and aesthetic medical devices, Establishment Labs produces the Motiva line of silicone-gel implants and the Motiva Flora tissue expander, sold in over 100 countries. Founded in 2004 by Juan José Chacón-Quirós, who started the company in his parents' house in Costa Rica, it became the first Costa Rican medtech firm to list on the Nasdaq in 2018. The Motiva brand name comes from the word "motive," reflecting the company's mission to put women's health first.
Bought 13.0K
Sold 301.9K
Bought 75.0K
Granted 45.2K · Sold 445.0K
Granted 297.2K · Bought 15.5K
Granted 54.8K · Bought 65.0K
Bought 10 · Sold 45.0K
Sold 50.0K
Granted 47.4K · Bought 2.9K
Granted 2.3K · Bought 4.0K
Granted 23.4K
Granted 24.1K
Granted 23.0K · Bought 2.3K
Granted 20.3K
Granted 22.2K · Sold 3.8K
Granted 36.4K · Sold 18.0K
Granted 7.4K
Granted 2.3K
Granted 3.2K
Granted 10.0K · Sold 10.0K
Granted 18.0K · Sold 18.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Wild Jason G. +4 co-filers10% owner · 8 transactions | — | 18.66Mas of Oct 2019 | — | 13.0K | — |
| Wild Jason G. +4 co-filersSee footnote 3 · 11 transactions | — | 15.02M | — | — | 301.9K |
| Wild Jason G. +4 co-filers10% owner · 6 transactions | — | 9.51Mas of May 2022 | — | 75.0K | — |
| Chacon Quiros Juan JoseDirector · 53 transactions | — | 4.59M | 45.2K | — | 445.0K |
| Lewin Nicholas SheridanDirector · 31 transactions | — | 1.10M | 297.2K | 15.5K | — |
| Schutter Edward JDirector · 30 transactions | — | 177.7K | 54.8K | 65.0K | — |
| De Mezerville RobertoChief Technology Officer · 13 transactions | — | 108.0Kas of May 2021 | — | 10 | 45.0K |
| Dada Santos SalvadorChief Operating Officer · 18 transactions | — | 100.0Kas of Jan 2021 | — | — | 50.0K |
| Caldini FilippoChief Executive Officer, Director · 7 transactions | — | 48.8K | 47.4K | 2.9K | — |
| Colleran Lisa NDirector · 5 transactions | — | 45.3Kas of Jun 2022 | 2.3K | 4.0K | — |
| Slotkin BryanDirector · 19 transactions | — | 32.6K | 23.4K | — | — |
| Custin AnnDirector · 16 transactions | — | 24.1K | 24.1K | — | — |
| Denhoy RajChief Financial Officer · 9 transactions | — | 23.3Kas of Mar 2025 | 23.0K | 2.3K | — |
| Mansbach Samuel RossGeneral Counsel and CCO · 7 transactions | — | 18.7K | 20.3K | — | — |
| Gillin LeslieDirector · 17 transactions | — | 18.4K | 22.2K | — | 3.8K |
| Condon Dennis EDirector · 22 transactions | — | 9.4Kas of Dec 2024 | 36.4K | — | 18.0K |
| de Oliveira EddieVP of Sales, Brazil · 1 transaction | — | 9.1Kas of Jul 2018 | — | — | — |
| Harris CassandraChief Financial Officer · 1 transaction | — | 7.4K | 7.4K | — | — |
| Dastidar PratipHead of Global Operations · 1 transaction | — | 6.8Kas of Apr 2022 | 2.3K | — | — |
| Harris Taylor C.Director · 2 transactions | — | 3.2K | 3.2K | — | — |
| Gaeta ReneeChief Financial Officer · 10 transactions | — | 2.1Kas of May 2021 | 10.0K | — | 10.0K |
| Gersh LisaDirector · 4 transactions | — | 0as of Aug 2021 | 18.0K | — | 18.0K |
| CPH Tu, LP10% owner · 2 transactions | — | 0as of May 2019 | — | — | — |
| Rodio Paul D.Chief Operating Officer · 1 transaction | — | 0as of Mar 2023 | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -714.0K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.